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are of questionable benefit unless associated with a survival
advantage and the dearth of randomised clinical trials is
noted. The recent presentation concerning just such a study
at this year's ASCO meeting suggests that secondary debulk-
ing surgery may indeed prolong survival.
Overall this is an enjoyable book that is easy to read, well
laid out and does aim to provide a comprehensive look at all
aspects of this disease. Although it is impossible to cover all
the controversial aspects of such a subject to everyone's
satisfaction, it does not attempt to be didactic and tries to be
as up-to-date as possible. I would warmly recommend it to
libraries and to anyone with a particular interest in ovarian
cancer management.
I. Judson
Photodynamic Therapy: Basic Principles and Clinical
Applications
Edited by B.W. Henderson & T.J. Dougherty, New York:
Marcel Dekker, 1992, 480 pp. $155.00
This multi-author book covers the spectrum from molecular
to clinical studies in the developing subject of photodynamic
therapy (PDT), also known as photochemotherapy. For a
modality to which the adjective 'novel' is invariably applied,
PDT has been intensively investigated over a period of years,
with a considerable expansion in the 1980s. There are indica-
tions that the subject is maturing, in that national or interna-
tional formal trials, as opposed to relatively small series on a
disparate range of tumour sites, are under way (chapter by
S.L. Marcus). Additionally, since the publication of this
book, the widely-used sensitiser Photofrin has received full
marketing approval in Canada, the first approval for clinical
use of a photosensitiser in any country. The hope is that this
recognition will release the regulatory 'log-jams' of applica-
tions worldwide.
Even its most ardent proponents recognise that Photofrin
is not ideal, and the book contains a number of articles
dealing with potential second-generation sensitisers, such as
the phthalocyanines (chapters of J. Moan, E. Ben-Hur, B.
Paquette) and the chlorins and their derivatives (A.R. Mor-
gan). The choice of classes of novel compounds has usually
been as a result of their photophysical properties, but it is of
interest in this book that the properties of drugs (and the
possibility of their manipulation) in relation to 'targeting'
pharmacokinetic carriers such as lipoproteins (G. Jori) or
antibodies (T. Hasan) are now being considered. Porphyrins
and their relatives are a chemist's delight in that the possi-
bilities for structural modification are legion; these become
particularly relevant when related to the properties of cells,
and in particular those that may distinguish some malignant
cells, at least, from their normal counterparts. A.R. Oseroff
advocates the use of cationic sensitisers on the imperfectly
understood grounds of, for example, possible differences in
cell and mitochondrial membrane potentials. Curiously, one
conclusion of the immediate preceding chapter was that
'positively-charged phthalocyanines are taken up poorly by
cells, as is generally true with positively charged molecules'.
The two authors may be talking about different things, but
the effect is confusing. A major omission from the book in
the light of recent interest is detailed discussion of the
manipulation of the endogenous haem pathway by adding
aminolaevulinic acid (ALA) exogenously to produce excess
intracellular protoporphyrin IX, which is an efficient photo-
sensitiser. The biologically short-lived ALA is now being
applied to patients investigationally and results are awaited
with keen interest.
The (bio)chemistry of PDT cannot be divorced from its
physics, in that the biological/clinical effect is the outcome of
the quantitative interactions of the two. Understanding of
this becomes more important as the developments of fibre-
optic delivery systems (W.M. Star) enable access to deep-
seated sites with sometimes critical surrounding or adjacent
organs. Endoscopic and fibre-optic methods measuring
photosensitiser fluorescence and tissue optical characteristics
in situ in patients offer approaches to a true 'photodynamic
dosimetry' (D. Braichotte).
The responses of cells and tissues to photodynamic insult
may be measured at a number of levels, and the article by
C.J. Gomer indicates that PDT has begun to dip its toe in
the waters of molecular biology, in a brief review of stress
responses and their transcriptional regulation. It is in the
response of normal tissues that further hopes are raised for
PDT, in the claims of excellent healing, i.e. re-epitheliali-
sation without scarring. This hope rests on a thin experi-
mental database, with much of the work being done and
reported here by S.G. Bown.
This book can be recommended as an good, largely up-to-
date, overview of an intrinsically complex (and scientifically
interesting) modality with applications considerably wider
than cancer, as some chapters describe. The hundred or so
pages ofclinical reports provide the expectation that the next
few years will reveal the actual utility of PDT both as a sole
modality and in combination with current therapies (the
latter a somewhat neglected area).
J.V. Moore